\-\ Texto\\:\\ \ \(0\)\
\-\ emg\\ positive\\ for\\ motor\\ neuron\\ disease\\.\\ \\ elevated\\ csf\\ protein\\.\ \(0\)\
\-\ steroids\ \(152\)\
\-\ \\â\\€\\¢\\ high\\ signal\\ intensity\\ changes\\ in\\ corticospinal\\ tracts\\ in\\ brain\\ bilaterally\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mild\\ cervical\\ spinal\\ cord\\ atrophy\\ with\\ absence\\ of\\ normal\\ cervical\\ spinal\\ cord\\ enlargement\\.\ \(0\)\
\-\ als\\,\\ amyotrophic\\ \\ lateral\\ \\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ als\\ \\(amyotrophic\\ lateral\\ sclerosis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ adem\ \(0\)\
\-\ \\â\\€\\¢\\ lyme\\ disease\ \(0\)\
\-\ 57\\ year\\ old\\ woman\\ with\\ 6\\ month\\ history\\ of\\ progressive\\ weakness\\ and\\ muscle\\ atrophy\\.\\ \\ bowel\\ and\\ bladder\\ incontinence\\ noted\\ more\\ recently\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ als\\:\\ 0\\.18821722281215583\ \(0\)\
\-\ amyotrophic\\:\\ 0\\.18120058689869775\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.11465958670213813\ \(0\)\
\-\ sclerosis\\:\\ 0\\.11229202073511017\ \(0\)\
\-\ atrophy\\:\\ 0\\.10753168723664012\ \(0\)\
\-\ corticospinal\\:\\ 0\\.08565559700900541\ \(0\)\
\-\ cord\\:\\ 0\\.07919936390744882\ \(0\)\
\-\ neuron\\:\\ 0\\.07826369696546498\ \(0\)\
\-\ cervical\\:\\ 0\\.07573393674613729\ \(0\)\
\-\ spinal\\:\\ 0\\.07462868805803868\ \(0\)\
\-\ tracts\\:\\ 0\\.06981068256839247\ \(0\)\
\-\ lyme\\:\\ 0\\.06450192560183338\ \(0\)\
\-\ adem\\:\\ 0\\.06282874119313234\ \(0\)\
\-\ emg\\:\\ 0\\.06221885801539257\ \(0\)\
\-\ incontinence\\:\\ 0\\.06163802814966995\ \(0\)\
\-\ 57\\:\\ 0\\.056788235861058856\ \(0\)\
\-\ protein\\:\\ 0\\.05347197103808761\ \(0\)\
\-\ steroids\\:\\ 0\\.049021071687436066\ \(0\)\
\-\ recently\\:\\ 0\\.04862444739834387\ \(0\)\
\-\ lateral\\:\\ 0\\.04504068403962318\ \(0\)\
\-\ motor\\:\\ 0\\.04351822380251234\ \(0\)\
\-\ csf\\:\\ 0\\.04351822380251234\ \(0\)\
\-\ absence\\:\\ 0\\.043327173598312355\ \(0\)\
\-\ bladder\\:\\ 0\\.042297693820110116\ \(0\)\
\-\ enlargement\\:\\ 0\\.04134839520103775\ \(0\)\
\-\ progressive\\:\\ 0\\.041188281890771984\ \(0\)\
\-\ weakness\\:\\ 0\\.03870257747595591\ \(0\)\
\-\ intensity\\:\\ 0\\.037666715565601236\ \(0\)\
\-\ muscle\\:\\ 0\\.037430673578370065\ \(0\)\
\-\ elevated\\:\\ 0\\.035357516601939795\ \(0\)\
\-\ bilaterally\\:\\ 0\\.034228112664925654\ \(0\)\
\-\ disease\\:\\ 0\\.034066769297944006\ \(0\)\
\-\ positive\\:\\ 0\\.03381567793029411\ \(0\)\
\-\ bowel\\:\\ 0\\.03268236015713121\ \(0\)\
\-\ brain\\:\\ 0\\.031357945406131245\ \(0\)\
\-\ month\\:\\ 0\\.03126359196098304\ \(0\)\
\-\ 6\\:\\ 0\\.031123416602132616\ \(0\)\
\-\ changes\\:\\ 0\\.02986643873457391\ \(0\)\
\-\ high\\:\\ 0\\.0285188544033758\ \(0\)\
\-\ signal\\:\\ 0\\.027476516222838764\ \(0\)\
\-\ mild\\:\\ 0\\.027442115291843136\ \(0\)\
\-\ more\\:\\ 0\\.026063125723319102\ \(0\)\
\-\ noted\\:\\ 0\\.024700258395763338\ \(0\)\
\-\ woman\\:\\ 0\\.02407198716449886\ \(0\)\
\-\ multiple\\:\\ 0\\.021948853700966695\ \(0\)\
\-\ normal\\:\\ 0\\.01633673725120855\ \(0\)\
\-\ history\\:\\ 0\\.014392860215940042\ \(0\)\
\-\ year\\:\\ 0\\.011659820356986766\ \(0\)\
\-\ old\\:\\ 0\\.010669934108076276\ \(0\)\
\-\ in\\:\\ 0\\.010277981222933047\ \(0\)\
\-\ for\\:\\ 0\\.008891562788325794\ \(0\)\
\-\ \\(\\:\\ 0\\.008809289344437324\ \(0\)\
\-\ \\)\\:\\ 0\\.008701679172113477\ \(0\)\
\-\ and\\:\\ 0\\.004390463554444352\ \(0\)\
\-\ \\,\\:\\ 0\\.003301342262405944\ \(0\)\
\-\ with\\:\\ 0\\.002853760392436335\ \(0\)\
\-\ of\\:\\ 0\\.002841556117024108\ \(0\)\
\-\ \\.\\:\\ 0\\.002597527031513142\ \(0\)\
